Golden Helix Newsletter

GenomeBrowse 2.0
GenomeBrowse 2.0 Is Here!
by Jessica Vionas, Director of Marketing

The developers at Golden Helix have raised the bar again with the release of GenomeBrowse 2.0. About a year and a half after the initial release, Golden Helix has expanded the functionality of GenomeBrowse to fulfill feature requests from both fundamental research investigators and transitional scientists who require a visualization tool to gain key insight into their results.

The Golden Helix GenomeBrowse® tool features impeccable genomic data visualization, giving researchers the power to navigate their sequence data in a fluid and dynamic way. Pairing a high performance backend with a streamlined user interface has given way to a discovery process that is this year's must have. And yes, GenomeBrowse 2.0 is still free! Continue reading »

A Transcription Factor for GenomeBrowse: Using Evernote to enable sharing genomic analysis
by Andrew Jesaitis, Product Manager and Software Engineer

Science is a collaborative endeavor. Rarely is it in isolation that new discovery takes place. Unfortunately, using a computer to perform analysis is almost always a solitary activity. Sharing what you have found with members of your team often means squeezing around a small 13" glowing rectangle.

While looking at the same screen has its place, being able to save your findings and share them with a another person is enormously valuable. Even if the only person with whom you are sharing is yourself in 12 hours, decoupling time from analysis means that never again will someone be left wondering where that interesting variant was or what made it interesting in the first place. Continue reading »

Adding Value Through Golden Helix Services
by Andreas Scherer, PhD, President & CEO
As I write this article, Golden Helix has hundreds of clients in top research institutions world-wide. The adoption of our product at these institutions ranges from a few individual users to site licenses used by entire organizations. Because of the quality of SNP & Variation Suite (SVS) and GenomeBrowse, our competence in the field is recognized, and increasingly our clients reach out to us to help them with their general bioinformatics needs. Continue reading »
   Upcoming Webcast
Genetic Underpinnings of Language Disorders
  Tues, May 13
12:00 pm EDT

Written and verbal language are vital to the development of communication skills. Unfortunately, disorders of these traits—specifically reading disability (RD) and language impairment (LI)—are common, leaving affected individuals at risk for adverse academic, socioeconomic, and psychiatric outcomes.

In this webcast, John Eicher of the Yale Child Health Research Center will discuss his search for shared genetic contributors

Webcast Registration

Under the Hood of Alignment Algorithms for NGS Researchers
Most NGS analysis is founded on a very simple and powerful principle: look only at the differences of your data to a reference genome of your species. View recording »

GenomeBrowse cited in Nature Genetics
A recent letter, "Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma," to Nature Genetics cites GenomeBrowse as a key resource. Find out more »

Facebook     Twitter     Linked In     Blog   YouTube

Recent Customer Success Highlights

Clinical Genetics
Whole exome analysis identifies dominant COL4A1 mutations in patients with complex ocular phenotypes involving microphthalmia
B. Deml et al.
John Wiley & Sons Ltd, New York, US
Read the article »

Brain, Behavior, and Immunity
Cytokine polymorphisms are associated with fatigue in adults living with HIV/AIDS
Kathryn A. Lee et al.
University of California, San Francisco, CA
Read the article »

About Golden Helix
Golden Helix has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over 15 years. Our innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from microarrays and next-generation sequencing. With our solutions, hundreds of the world's top pharmaceutical, biotech, and academic research organizations are able to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in over 800 peer-reviewed publications.


Copyright 2000-2014 Golden Helix, Inc. All Rights Reserved.
Golden Helix, Inc. | 203 Enterprise, Blvd. | Bozeman, MT | 59718